GLOW
Multi-Peptide Skin Rejuvenation Complex
DoseGear research brief
Combination featuring BPC-157, TB-500, and GHK-Cu marketed for skin rejuvenation and anti-aging. Individual components have research support, but combination protocols require careful dosing to avoid exceeding therapeutic ranges.
BPC-157 provides anti-inflammatory effects; TB-500 supports angiogenesis; GHK-Cu stimulates collagen production. Fixed-ratio combinations may deliver individual peptides outside optimal therapeutic ranges.
Compound background
Study windows describe what researchers measured, not when an individual should expect a result.
Marketed BPC-157, TB-500, and GHK-Cu combination; a specific developer is not established.
Proposed skin and repair applications based on ingredient mechanisms; the combination itself is unvalidated.
Not reported for the blend.
Reference data
Not personalized dosing instructions
Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.
| Research context | Amount | Frequency | Route |
|---|---|---|---|
| Standard protocol | Per formulation instructions | Once daily | Subcutaneous |
Reference cycle
8-12 weeks
Reference storage
Lyophilized: 2-8°C refrigerated; Reconstituted: 2-8°C refrigerated immediately after mixing
No profile entries reported.
Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteers
No Published Studies on GLOW Combination
This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.
